Ergoteles LLC Angion Biomedica Corp. Transaction History

Ergoteles LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$0.8 - $1.0 $20,755 - $25,944	-25,944 Reduced 32.9%	52,913 $42,000
Q3 2022 Nov 14, 2022	SELL	$0.94 - $1.23 $9,846 - $12,884	-10,475 Reduced 11.73%	78,857 $73,000
Q2 2022 Aug 12, 2022	BUY	$1.1 - $2.23 $98,265 - $199,210	89,332 New	89,332 $102,000
Q3 2021 Nov 15, 2021	SELL	$9.31 - $13.25 $222,667 - $316,900	-23,917 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$13.02 - $17.83 $311,399 - $426,440	23,917 New	23,917 $311,000

Ticker ANGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,113,300
Description
Angion Biomedica Corp., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapeutics for acute organ injuries and fibrotic diseases. The company's lead product candidate is ANG-3070, an oral tyrosine kinase receptor inhibitor in development as a treatment for fibrotic diseases, primaril...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.